Clinical trial
A Prospective, Multicenter, Non-Interventional Study Evaluating the Bleeding Incidence in Patients With Von Willebrand Disease Undergoing On-Demand Treatment
NCT04053699 is registered in ClinicalTrials.gov with Octapharma as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Multicenter, Non-Interventional Study Evaluating the Bleeding Incidence in Patients With Von Willebrand Disease Undergoing On-Demand Treatment
- Lead sponsor
- Octapharma
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 25, 2019
- Completion date
- January 31, 2021
- Enrollment
- 56 (actual)
- Sites
- 15
Conditions
As the registry lists them; a condition with its own page is linked.